Isabel Cerro-Pardo Selected Research

Pancreatic Elastase (Elastase)

1/2022

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabel Cerro-Pardo Research Topics

Disease

3	Abdominal Aortic Aneurysm 01/2022 - 10/2021
2	Atherosclerosis 02/2022 - 01/2022
1	Aneurysm (Aneurysms) 01/2023
1	Vascular Remodeling 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Thrombosis (Thrombus) 10/2021

Drug/Important Bio-Agent (IBA)

1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 02/2022
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	Apolipoproteins AIBA 02/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	LipidsIBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	Galectin 1 (LGALS1)IBA 01/2022
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 10/2021
1	Malondialdehyde (Propanedial)IBA 10/2021
1	Conditioned Culture MediaIBA 10/2021
1	HDL LipoproteinsIBA 10/2021